AGGRESSIVE FIBROMATOSIS
Clinical trials for AGGRESSIVE FIBROMATOSIS explained in plain language.
Never miss a new study
Get alerted when new AGGRESSIVE FIBROMATOSIS trials appear
Sign up with your email to follow new studies for AGGRESSIVE FIBROMATOSIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Fertility check: can a tumor drug safely treat young women?
Disease control Recruiting nowThis study aims to understand how the approved desmoid tumor drug nirogacestat affects ovarian function and fertility in premenopausal women. It will enroll 50 women aged 18-40 to monitor their menstrual cycles and hormone levels while taking the medication. The goal is to measur…
Matched conditions: AGGRESSIVE FIBROMATOSIS
Phase: PHASE4 • Sponsor: SpringWorks Therapeutics, Inc. • Aim: Disease control
Last updated Mar 31, 2026 12:11 UTC
-
New pill tested to shrink rare, painful tumors in japanese patients
Disease control Recruiting nowThis study is testing an oral medication called nirogacestat in Japanese adults whose desmoid tumors are growing. Desmoid tumors are rare, non-cancerous growths that can cause pain and limit movement. The goal is to see if the drug can shrink these tumors and is safe for this spe…
Matched conditions: AGGRESSIVE FIBROMATOSIS
Phase: PHASE2 • Sponsor: SpringWorks Therapeutics, Inc. • Aim: Disease control
Last updated Mar 30, 2026 14:35 UTC